Is it “ off label “ if RecoveryRX is applied for post op pain and edema and there is incidental “ wound healing “ BTW treating for post op edema is part and parcel of “ wound care “ isn’t it? If that is the case then a strong case could be made that RecoveryRX is already explicitly cleared for “ wound care “ wouldn’t it?
An inquiry to the FDA for clarification of terms for purposes of proposed changes for product labeling may be warranted here imo.
News 
Market Data 
Discover 
